<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02175576</url>
  </required_header>
  <id_info>
    <org_study_id>ORTHO.CR.GK9B</org_study_id>
    <nct_id>NCT02175576</nct_id>
  </id_info>
  <brief_title>Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System</brief_title>
  <acronym>GK9B</acronym>
  <official_title>Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized Controlled Study to determine if preservation of ligaments provides increased
      functional ability post-operatively in comparison to traditional TKA which sacrifices soft
      tissue.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized Controlled Study to compare clinical and patient reported outcomes of the Vanguard
      XP Bicruciate Total Knee System to the Vanguard CR Knee System through 10 years of follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 2014</start_date>
  <completion_date type="Anticipated">October 2026</completion_date>
  <primary_completion_date type="Anticipated">October 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Modified Knee Society Score</measure>
    <time_frame>12 months</time_frame>
    <description>The objective component of the Knee Society score will be collected by clinical personnel. The pain and function component of the score will be patient complete questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>Pre-op, Post op at 3 &amp; 6 month, 1, 2, 3, 5, 7 &amp; 10 year intervals</time_frame>
    <description>Serious and device related adverse events will be collected for the duration of the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survivorship</measure>
    <time_frame>Post op at 1, 2, 3, 5, 7 &amp; 10 year intervals</time_frame>
    <description>KM survivorship will be calculated based on device revisions and removals through out duration of the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Reported Outcome Measures on KOOS</measure>
    <time_frame>12 months</time_frame>
    <description>Patients will complete questionnaires to determine overall satisfaction and outcomes of TKA including KOOS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Reported Outcome Measures on Oxford Knee Score</measure>
    <time_frame>12 months</time_frame>
    <description>Patients will complete questionnaires to determine overall satisfaction and outcomes of TKA including Oxford Knee Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Patient Reported Outcome Measures on EQ 5D</measure>
    <time_frame>12 months</time_frame>
    <description>Patients will complete questionnaires to determine overall satisfaction and outcomes of TKA including EQ-5D</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">306</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Traumatic Arthritis</condition>
  <condition>Lower Limb Deformity</condition>
  <condition>Post-traumatic Deformity</condition>
  <condition>Complications, Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Vanguard XP Bicruciate Knee System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>153 patients receive Vanguard XP Bicruciate Knee System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vanguard CR Knee System</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>153 patients receive Vanguard CR Knee System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vanguard XP Bicruciate Knee System</intervention_name>
    <description>The Vanguard XP is a bicruciate retaining total knee design and is constrained by natural soft tissue.</description>
    <arm_group_label>Vanguard XP Bicruciate Knee System</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vanguard CR Knee System</intervention_name>
    <description>The Vanguard CR system requires the ACL to be sacrificed and is constrained by soft tissue and device design.</description>
    <arm_group_label>Vanguard CR Knee System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  cemented application of components

          -  bilateral subjects randomized by knee

          -  patients with pre-existing contralateral knee surgery

          -  painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis,
             or traumatic arthritis where one or more compartments are involved

          -  correction of varus, valgus, or posttraumatic deformity

          -  sufficient soft tissue surrounding the knee, including the Anterior Cruciate Ligament

        Exclusion Criteria:

          -  cementless application of components

          -  BMI greater than or equal to 40

          -  use of Anterior Stabilized Bearings

          -  patients with severe pre-operative varus or valgus deformity greater than or equal to
             15 degrees

          -  correction or revision of previous joint replacement procedure on index knee

          -  infection

          -  sepsis

          -  osteomyelitis

        Relative exclusion criteria:

          -  uncooperative patient or patient with neurological disorders who is incapable of
             following directions

          -  osteoporosis

          -  metabolic disorders which may impair bone formation

          -  osteomalacia

          -  distant foci of infections which may spread to the implant site

          -  rapid joint destruction, marked bone loss, or bone resorption apparent on
             roentgenogram

          -  vascular insufficiency, muscular atrophy, neuromuscular disease

          -  incomplete or deficient soft tissue surrounding the knee, including the anterior
             cruciate ligament
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kacy Arnold, RN, MBA</last_name>
    <role>Study Director</role>
    <affiliation>Zimmer Biomet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Midwest Orthopaedics at Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah Orthopaedic Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 24, 2014</study_first_submitted>
  <study_first_submitted_qc>June 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2014</study_first_posted>
  <last_update_submitted>July 18, 2019</last_update_submitted>
  <last_update_submitted_qc>July 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

